tiprankstipranks
Trending News
More News >
Intellia Therapeutics announces first patient dosed in MAGNITUDE-2 trial
PremiumThe FlyIntellia Therapeutics announces first patient dosed in MAGNITUDE-2 trial
1M ago
Biotech stocks slide as Marks resignation seen being negative for sector
Premium
The Fly
Biotech stocks slide as Marks resignation seen being negative for sector
1M ago
BMO says Peter Marks resignation ‘significant negative’ for biotech
Premium
The Fly
BMO says Peter Marks resignation ‘significant negative’ for biotech
1M ago
Intellia Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe FlyIntellia Therapeutics initiated with a Buy at H.C. Wainwright
2M ago
Intellia Therapeutics price target lowered to $50 from $90 at Truist
Premium
The Fly
Intellia Therapeutics price target lowered to $50 from $90 at Truist
2M ago
Intellia Therapeutics: Promising Potential in Biotech with NTLA-2002 Advancements and Strategic Focus
Premium
Ratings
Intellia Therapeutics: Promising Potential in Biotech with NTLA-2002 Advancements and Strategic Focus
2M ago
Intellia Therapeutics price target lowered to $37 from $47 at RBC Capital
PremiumThe FlyIntellia Therapeutics price target lowered to $37 from $47 at RBC Capital
2M ago
Intellia Therapeutics: Strategic Positioning and Growth Potential Justify Buy Rating
Premium
Ratings
Intellia Therapeutics: Strategic Positioning and Growth Potential Justify Buy Rating
2M ago
Goldman downgrades Intellia to Sell on challenging commercial outlook
Premium
The Fly
Goldman downgrades Intellia to Sell on challenging commercial outlook
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100